Expand MYGN Menu
MYGN MENU

MYGN Latest Press Releases

-- April 17, 2024 --

Nearly Half of Americans Say They've Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor Globe Newswire 8:00 AM

-- April 16, 2024 --

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel Prenatal Screen Globe Newswire 9:15 AM

-- April 9, 2024 --

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing Globe Newswire 8:00 AM

-- March 21, 2024 --

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date Globe Newswire 9:40 PM

-- March 20, 2024 --

Myriad Genetics Announces Patent Granted for SneakPeek Snap Device Globe Newswire 4:05 PM

-- February 27, 2024 --

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3 Globe Newswire 9:15 AM

-- February 21, 2024 --

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 Globe Newswire 4:05 PM

-- February 15, 2024 --

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women's Health Globe Newswire 4:05 PM

-- February 1, 2024 --

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics Globe Newswire 9:25 AM

-- January 30, 2024 --

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology Globe Newswire 5:00 PM

-- January 18, 2024 --

Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics Globe Newswire 6:10 PM

-- January 9, 2024 --

Myriad Genetics Applauds New Germline Testing Guideline for Patients with Breast Cancer from ASCO-SSO Globe Newswire 4:05 PM

-- January 3, 2024 --

Myriad Genetics to Present at 42nd Annual J.P. Morgan Healthcare Conference Globe Newswire 4:05 PM

-- December 21, 2023 --

Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance Globe Newswire 8:30 AM

-- December 20, 2023 --

Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care Globe Newswire 8:00 AM